http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104634959-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-531 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-531 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104634959-B |
| titleOfInvention | A kind for the treatment of fluid and use it to measure the method for antigenic content in aluminium salt absorbent-type vaccine |
| abstract | The invention discloses the treatment fluid of a kind of antigen in desorption aluminium salt absorbent-type vaccine, described treatment fluid is phosphate buffer or citrate buffer, and comprises protein and one or more acid and/or their salt.The invention also discloses and a kind of use this process also to detect the method for antigenic content in aluminium salt absorbent-type vaccine.The inventive method decreases the interference to antigen content detection of the aluminium adjuvant in Vaccinum Encephalitidis Epidemicae, for a kind of can quickly, the method for antigenic content in Accurate Determining absorbent-type Inactivated Japanese Encephalitis Vaccine.Additionally, the method for the present invention has, ruggedness is strong, accuracy and the high feature of precision, can be that the quality control of aluminium adjuvant absorbent-type Japanese encephalitis inactivated vaccine provides reference. |
| priorityDate | 2013-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.